Opposed independent effects and epistasis in the complex association of IRF5 to SLE

Genes and Immunity

Volumn 8, Issue 5, 2007, Pages 429-438

  Ferreiro Neira, I ^a   Calaza, M ^a   Alonso Perez, E ^a   Marchini, M ^b   Scorza, R ^b   Sebastiani, G D ^c   Blanco, F J ^d   Rego, I ^d   Pullmann Jr , R ^e   Pullmann, R ^e   Kallenberg, C G ^f   Bijl, M ^f   Skopouli, F N ^g   Mavromati, M ^g   Migliaresi, S ^h   Barizzone, N ⁱ   Ruzickova, S ^j   Dostal, C ^j   Schmidt, R E ^k   Witte, T ^k   Papasteriades, C ^l   Kappou Rigatou, I ^l   Endreffy, E ^m   Kovacs, A ^m   Ordi Ros, J ⁿ   Balada, E ⁿ   Carreira, P ^o   Gomez Reino, J J ^a,p   Gonzalez, A ^a   more..

^a Instituto de Salud Carlos III   (Spain)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d Servicio de Reumatologia   (Spain)

^e MARTIN FACULTY HOSPITAL   (Slovakia)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^j INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l EVANGELISMOS HOSPITAL   (Greece)

^m UNIVERSITY OF SZEGED   (Hungary)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^p UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 5; MESSENGER RNA; PROLINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; EUROPE; EXON; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; COHORT STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34547541897     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364407     Document Type: Article

References (32)

1. Croker JA, Kimberly RP. SLE: Challenges and candidates in human disease. Trends Immunol 2005; 26: 580-586.
2. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type I interferons. Curr Opin Immunol 2006; 18 676-682.
3. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol 2004; 16 794-800.
4. Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529-537.
5. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528-537.
6. Demirci FY, Manzi S, Ramsey-Goldman R, Minster RL, Kenney M, Shaw PS et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet 2006; 71: 308-311.
7. Graham DS, Manku H, Wagner S, Reid J, Timms K, Gutin A et al. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet 2007; 16: 579-591.
8. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550-555.
9. Kozyrev SV, Lewen S, Reddy PM, Pons-Estel B,Witte T, Junker P et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1234-1241.
10. Shin HD, Sung YK, Choi CB, Lee SO, Lee HW, Bae SC et al. Replication of genetic effects of interferon regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther 2007; 9: R32.
11. Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 2005; 280 21078-21090.
12. Consortium IH. A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
13. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
14. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
15. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007; 104: 6758-6763.
16. Li SS. Specificity and versatility of SH3 and other proline-recognition domains: Structural basis and implications for cellular signal transduction. Biochem J 2005; 390: 641-653.
17. Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001; 276: 23382-23390.
18. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H et al. Identification of the interferon regulatory factor 5 gene (IRF-5 as a direct target for p53. Oncogene 2002; 21: 2914-2918.
19. Hu G, Mancl ME, Barnes BJ. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 2005; 65: 7403-7412.
20. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA 2007; 104: 3402-3407.
21. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 2005; 280: 17005-17012.
22. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T et al. Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature 2005; 434: 243-249.
23. Ouyang X, Negishi H, Takeda R, Fujita Y, Taniguchi T, Honda K et al. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007; 354: 1045-1051.
24. Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 2002; 22: 5721-5740.
25. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM et al. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 2004; 279: 45194-45207.
26. Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects. Arthritis Rheum 2004; 50: 2590-2597.
27. Ferreiros-Vidal I, D'Alfonso S, Papasteriades C, Skopouli FN, Marchini M, Scorza R et al. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun 2007; 8: 138-146.
28. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
30. Schneider S, Roesli D, Excoffier L. Arlequin ver 2000 A: Software for Population Genetics Data Analysis. Genetics and Biometry Laboratory, University of Geneva: Switzerland, 2000.
31. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68 978-989.
32. Goudet J, Raymond M, de Meeus T, Rousset F. Testing differentiation in diploid populations. Genetics 1996; 144: 1933-1940.